Rheumatology

Latest News

Rheumatoid arthritis in hand | Image credit: yodiyim – stock.adobe.com
Subcutaneous Tocilizumab Superior to Methotrexate in Chinese Patients With RA

June 12th 2025

Tocilizumab alone and in combination with methotrexate outperformed the latter drug in patients who did not adequately respond to conventional synthetic disease-modifying antirheumatic drugs.

The connection between anemia and mortality among patients with RA could likely be explained by inflammation, explained the researchers. | Image credit: Matthieu - stock.adobe.com
Anemia Linked With Higher Risk of All-Cause, CVD-Related Mortality in Rheumatoid Arthritis

May 30th 2025

The authors wanted to better understand the problem of avoidable hospitalizations among people with rheumatoid arthritis. | Image credit: everythingpossible - stock.adobe.com
Rheumatoid Arthritis Linked With Heightened Risk of Avoidable Hospitalizations

May 8th 2025

Because serum analysis is already used to diagnose RA, track its progression, and understand response to therapy, the authors investigated whether reliable biomarkers could be found for refractory RA. | Image credit: angellodeco - stok.adobe.com
Serum Biomarkers for Refractory Active Rheumatoid Arthritis Remain Elusive

April 28th 2025

Using Telemedicine Interventions During COVID-19 to Expand Care Post COVID-19

January 24th 2023

More News

Body images with highlighted joints
July 23rd 2021

Secukinumab Effective in Patients With Psoriatic Arthritis Regardless of TNFi History

Jared Kaltwasser
Patients who were tumor necrosis factor inhibitor naive generally had better responses to secukinumab compared with those who were inadequate responders—but both groups benefited
Site Logo
July 20th 2021

Association of Physician Specialty With Psoriatic Arthritis Treatment and Costs

Ervant J. Maksabedian Hernandez, PhD, MPhil Joseph Tkacz, MS Nicole M. Zimmerman, MS Philip Chan, PhD, MS Brendan Limone, PharmD Alexis Ogdie, MD, MSCE Elaine Karis, MD Bradley Stolshek, PharmD
In this retrospective cohort study of patients with newly diagnosed psoriatic arthritis, the authors examine the association of treatment selection and costs with physician specialty.
Graphic of blood vessels
July 13th 2021

Treatment, Management Guidelines for 6 Forms of Vasculitis Released

AJMC Staff
Treatment options for patients with these rare diseases have expanded in recent years, but rheumatologists may have limited experience with systemic vasculitis.
Patient with arthritis
July 12th 2021

Review Finds Biomarker Linked With PsA Development in Patients With Psoriasis

Jared Kaltwasser
No clinical or genetic markers were found to be predictive of psoriatic arthritis in patients with psoriasis, but one laboratory marker was identified.
pill graphic
July 9th 2021

Review Outlines Pharmacologic Properties Secukinumab, Future Personalization Opportunities

Jared Kaltwasser
A new review shows secukinumab continued to have a strong safety profile after 6 years on the market.
Image of woman holding painful hand
June 30th 2021

Self-management for Inflammatory Arthritis Seems Effective but Needs More Research, Study Says

Jared Kaltwasser
A systematic review found significant evidence supporting self-management interventions for inflammatory arthritis, but also found it was difficult to draw conclusions about specific types of programs.
person having knee pain
June 25th 2021

Rheumatology Rundown: Protein Biomarker Differentiates PsA From RA, Improving Vaccine Uncertainty, New Upadacitinib Results

Skylar Jeremias
The latest news in the rheumatology space revealed potential biomarkers for differentiating psoriatic arthritis (PsA) from rheumatoid arthritis (RA), as well as other rheumatology news reported across MJH Life Sciences™.
Enhanced photo of arthritis-sore joints
June 23rd 2021

Secukinumab Retention High in Real-world Study of Patients With PsA, AxSpA

Jared Kaltwasser
Clinical trials and postmarketing surveillance suggest secukinumab has a favorable safety profile and low rates of discontinuation. A new study evaluated those metrics in a real-world setting in axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA).
Image of injections
June 16th 2021

Most Patients With RA on Biologic DMARDs Prefer Self-administration

Jared Kaltwasser
About one-third of patients prefer in-hospital administration, particularly if they are older or already make frequent visits to the hospital.
xray showing joint pain
June 11th 2021

Secukinumab Shown to Improve Enthesitis in Patients With Ankylosing Spondylitis

Skylar Jeremias
Patients with ankylosing spondylitis taking secukinumab saw improvements in enthesitis, and some achieved complete resolution, suggesting the drug could be a viable option for patients intolerant of or unresponsive to other enthesitis-improving medications.
Downward arrow
June 5th 2021

Pair of Studies Show Slide of Heart Failure, Dementia in RA After Entry of Biologics

Allison Inserro
The studies used population-level data from a county in Minnesota that has served as a national laboratory for health research since the 1960s.
Impact of PsA Magnified When Disease Affects Multiple Areas
May 29th 2021

Impact of PsA Magnified When Disease Affects Multiple Areas

Allison Inserro
Using a large US database, researchers characterized the impact of psoriatic arthritis (PsA) in patients with disease activity in multiple domains vs those with disease activity affecting a single area.
syringe in front of pills
May 26th 2021

Review Assesses Impact of Methotrexate in Patients With RA

Larry Hanover
Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population.
a picture of a doctors office
May 22nd 2021

Rheumatology Rundown: Birth Control Guidance, Gene Therapy, Gout Treatment

AJMC Staff
Birth control guidance provided to women taking rheumatoid arthritis therapies is lacking, and other rheumatology news reported across MJH Life Sciences™.
a picture of an MRI machine
May 22nd 2021

Study: Using Imaging to Predict RA Progression Doesn’t Add Precision to Findings

Allison Inserro
Ultrasounds and MRI are both used to monitor inflammation activity in rheumatoid arthritis, but their value in refining future treatment strategies has so far been unknown.
Rheumatology Rundown: Pregnancy and Lupus, Attitudes Toward Exercise, and More
May 15th 2021

Rheumatology Rundown: Pregnancy and Lupus, Attitudes Toward Exercise, and More

AJMC Staff
Some of the latest rheumatology news includes updates on pregnancy, exercise, and treatment for psoriatic arthritis.
Examining Mortality Risk Factors in Ankylosing Spondylitis
May 14th 2021

Examining Mortality Risk Factors in Ankylosing Spondylitis

Larry Hanover
Ankylosing spondylitis (AS) patients face a greater risk of mortality, but treatment with tumor necrosis factor inhibitors erases it.
Patients With Refractory Psoriasis Helped by Combination Therapy, Case Study Finds
May 8th 2021

Patients With Refractory Psoriasis Helped by Combination Therapy, Case Study Finds

Larry Hanover
Using acitretin in combination with secukinumab resulted in nearly complete or total relief for 3 patients with severe psoriasis, according to a case study.
pill bottle spilled over dollar bills
May 7th 2021

Analysis: Early Diagnosis of RA Leads to Thousands of Dollars in Savings

Jared Kaltwasser
About 90% of patients are diagnosed with rheumatoid arthritis in an outpatient setting, while the 10% diagnosed in an emergency department or as inpatients incur significantly higher health care costs.
Review examines role of IL-6 in RA pain
April 29th 2021

Review Examines Role of Interleukin-6 in Rheumatoid Arthritis Pain

Larry Hanover
A proportion of rheumatoid arthritis pain may be more appropriately considered separate from inflammation and should be treated as a focus of its own.
man's hand with psoriasis rash
April 24th 2021

Researchers Review Practice Guidelines for Biologics in Psoriasis

Skylar Jeremias
Guidelines on the use of biologic drugs in patients with psoriasis were mostly seen as having medium-to-high quality; however, investigators said that more work needs to be done to ensure applicability to clinical practice.
Injection pen
April 23rd 2021

Adalimumab, Rituximab Most Commonly Used Anti-inflammatory Agents, Says Longitudinal Study

Jaime Rosenberg
Adalimumab was the most commonly used tumor necrosis factor-alpha inhibitor (TNFi), accounting for 47% of 90,000 incidences of TNFi use. Rituximab was the most commonly used non-TNFi, for 44% of 70,000 incidences of non-TNFi use.
UK Biobank Study Finds Elevated Risk of Death From COVID-19 in Those With RA
April 17th 2021

UK Biobank Study Finds Elevated Risk of Death From COVID-19 in Those With RA

AJMC Staff
Researchers did not find an association in people who had gout.
health graphic
April 10th 2021

Understanding the Risk of MGUS Progression to MM in Patients with Rheumatologic Diseases

Larry Hanover
The risk for patients with monoclonal gammopathy of undetermined significance developing multiple myeloma is double if they have a specific category of rheumatic diseases compared with those without the diseases.
pills, syringe photograph
April 9th 2021

Assessing the Pandemic’s Impact on DMARD Use Among Patients With RA

Larry Hanover
COVID-19 led many patients to change their use of disease-modifying antirheumatic drugs in the pandemic’s initial months, with or without physician guidance.
Artistic rendering of autoimmune cells
April 3rd 2021

Behçet Disease Linked With Rheumatoid Arthritis, MS, Study Says

Larry Hanover
Behçet disease (BD), a rare systemic inflammatory disease, is associated with multiple sclerosis (MS) and rheumatoid arthritis (RA).
Image of cancer cell
April 3rd 2021

Study Examines Links Around Chronic Inflammatory Rheumatic Disease, Cancer

Larry Hanover
In patients with chronic inflammatory rheumatic and musculoskeletal diseases (RMD), the presence of metabolic syndrome (MetS) indicates an increased risk of cancer.
Senate Bill Seeks to Limit Use of Step Therapy in Employer Health Plans
March 27th 2021

Senate Bill Seeks to Limit Use of Step Therapy in Employer Health Plans

AJMC Staff
The bipartisan bill spells out 5 step therapy exemptions for patients by amending the Employee Retirement Income Security Act of 1974.
Cigna Dangles $500 to Persuade Patients to Switch Psoriasis Drugs
March 26th 2021

Cigna Dangles $500 to Persuade Patients to Switch Psoriasis Drugs

Allison Inserro
As the first quarter of 2021 ends, patients choosing to keep using secukinumab may be offered an inducement to switch to another biologic, ixekizumab.
Nail Psoriasis Needs Common Diagnosis, Assessment Standards, Review Says
March 19th 2021

Nail Psoriasis Needs Common Diagnosis, Assessment Standards, Review Says

Larry Hanover
There is a lack of standards for diagnosing and treating nail psoriasis, a situation needing attention because the condition is often a precursor to psoriatic arthritis.
<123456789
...
11>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo